86 related articles for article (PubMed ID: 8454414)
1. Review of a novel hematopoietic cytokine, interleukin-11.
Quesniaux VF; Mayer P; Liehl E; Turner K; Goldman SJ; Fagg B
Int Rev Exp Pathol; 1993; 34 Pt A():205-14. PubMed ID: 8454414
[TBL] [Abstract][Full Text] [Related]
2. Preclinical biology of interleukin 11: a multifunctional hematopoietic cytokine with potent thrombopoietic activity.
Goldman SJ
Stem Cells; 1995 Sep; 13(5):462-71. PubMed ID: 8528095
[TBL] [Abstract][Full Text] [Related]
3. The biology of interleukin 11.
Neben S; Turner K
Stem Cells; 1993 Jul; 11 Suppl 2():156-62. PubMed ID: 8401258
[TBL] [Abstract][Full Text] [Related]
4. Administration of human recombinant IL-7 to normal and irradiated mice increases the numbers of lymphocytes and some immature cells of the myeloid lineage.
Faltynek CR; Wang S; Miller D; Young E; Tiberio L; Kross K; Kelley M; Kloszewski E
J Immunol; 1992 Aug; 149(4):1276-82. PubMed ID: 1500718
[TBL] [Abstract][Full Text] [Related]
5. Modulation of early B lymphopoiesis by interleukin-3.
Ball TC; Hirayama F; Ogawa M
Exp Hematol; 1996 Aug; 24(10):1225-31. PubMed ID: 8765498
[TBL] [Abstract][Full Text] [Related]
6. IL-6 interferes with stimulation of HPP-CFC and large CFU-Mk in conjunction with cytokine combinations from primitive murine marrow cells.
Cardier JE; Murphy MJ; Erickson-Miller CL
Stem Cells; 1997; 15(6):437-42. PubMed ID: 9402656
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells.
Lazzari L; Henschler R; Lecchi L; Rebulla P; Mertelsmann R; Sirchia G
Haematologica; 2000 Jan; 85(1):25-30. PubMed ID: 10629587
[TBL] [Abstract][Full Text] [Related]
8. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
9. Constant subcutaneous infusion of rhIL-11 in mice: efficient delivery enhances biological activity.
Leonard JP; Neben TY; Kozitza MK; Quinto CM; Goldman SJ
Exp Hematol; 1996 Feb; 24(2):270-6. PubMed ID: 8641352
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin-independent erythroid colony formation by bone marrow progenitors exposed to interleukin-11 and interleukin-8.
Corre-Buscail I; Pineau D; Boissinot M; Hermouet S
Exp Hematol; 2005 Nov; 33(11):1299-308. PubMed ID: 16263414
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-11.
Kobayashi S; Teramura M; Oshimi K; Mizoguchi H
Leuk Lymphoma; 1994 Sep; 15(1-2):45-9. PubMed ID: 7532057
[TBL] [Abstract][Full Text] [Related]
12. Immunologic and hematopoietic effects of CD40 stimulation after syngeneic bone marrow transplantation in mice.
Funakoshi S; Taub DD; Anver MR; Raziuddin A; Asai O; Reddy V; Rager H; Fanslow WC; Longo DL; Murphy WJ
J Clin Invest; 1997 Feb; 99(3):484-91. PubMed ID: 9022082
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 11.
Quesniaux VF
Leuk Lymphoma; 1994 Jul; 14(3-4):241-9. PubMed ID: 7950912
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 1 receptor antagonist inhibits normal hematopoiesis and reduces lethality and bone marrow toxicity of 5-fluouracil in mouse.
Zhang J; Xiang D; Zhu S; Mao W; Lu H; Wu M; Wang Q; Yu Y; Herbst KD; Han W
Biomed Pharmacother; 2009 Aug; 63(7):501-8. PubMed ID: 18980827
[TBL] [Abstract][Full Text] [Related]
15. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.
Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T
Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-3 in hematology and oncology: current state of knowledge and future directions.
Mangi MH; Newland AC
Cytokines Cell Mol Ther; 1999 Jun; 5(2):87-95. PubMed ID: 10515681
[TBL] [Abstract][Full Text] [Related]
17. In vivo effects of pegylated recombinant human megakaryocyte growth and development factor on hematopoiesis in normal mice.
Kabaya K; Akahori H; Shibuya K; Nitta Y; Ida M; Kusaka M; Kato T; Miyazaki H
Stem Cells; 1996 Nov; 14(6):651-60. PubMed ID: 8948023
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-induced expansion of human CD34+ stem/progenitor and CD34+CD41+ early megakaryocytic marrow cells cultured on normal osteoblasts.
Ahmed N; Khokher MA; Hassan HT
Stem Cells; 1999; 17(2):92-9. PubMed ID: 10195569
[TBL] [Abstract][Full Text] [Related]
19. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program.
Valtieri M; Tocci A; Gabbianelli M; Luchetti L; Masella B; Vitelli L; Botta R; Testa U; Condorelli GL; Peschle C
Cancer Res; 1998 Feb; 58(3):562-9. PubMed ID: 9458106
[TBL] [Abstract][Full Text] [Related]
20. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis.
Ichikawa M; Asai T; Saito T; Seo S; Yamazaki I; Yamagata T; Mitani K; Chiba S; Ogawa S; Kurokawa M; Hirai H
Nat Med; 2004 Mar; 10(3):299-304. PubMed ID: 14966519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
